Report Highlights
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Report Includes
- 32 data tables and 39 additional tables
- An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
- Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
- A look at ESG trends
- Information on developments in R&D, clinical trials, emerging technologies, and economic trends
- Analysis of key companies’ market shares, proprietary technologies, patents, and alliances
- Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA
Report Scope
This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.
Report Synopsis
| Report Metrics | Details | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||
| Forecast period considered | 2024-2029 | ||||||||
| Base year market size | $14.7 billion | ||||||||
| Market size forecast | $30.2 billion | ||||||||
| Growth rate | CAGR of 13.1% for the forecast period of 2024-2029 | ||||||||
| Units considered | $ Millions | ||||||||
| Segments covered | Product, Indication, Application, and Region | ||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||
| Countries covered | China, India, Japan, Malaysia, Singapore U.S., Canada, Mexico, Germany, U.K., France, Italy, and Spain | ||||||||
| Key Market Drivers |
|
||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Report Highlights
The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.
Report Includes
- 59 tables
- An overview and industry analysis of the global markets for metabolomics technologies
- Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
- Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
- Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomic research and spending in pharmaceutical and biotech R&D
- Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
- Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific
Report Highlights
The global market for metabolomics should grow from $9.8 billion in 2018 to reach $17.1 billion by 2023 at a compound annual growth rate (CAGR) of 11.9% for the period of 2018-2023.
Report Includes
- 86 data tables and 16 additional tables
- Brief overview and industry analysis of the global markets for metabolomics technologies
- Analyses of global market trends with data from 2016 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
- Examination of the main structure of the metabolomics market by segments, key application areas, and market participants
- Market dynamics and estimated data regarding metabolomics by technological platforms (analytical instruments), detection techniques, separation techniques, assays, disease indication types, applications and geographical regions
- Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading companies in the metabolomics market, including LECO Corp., Metabolon Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp.
Report Highlights
The global metabolomic market totaled $5.9 billion in 2014 and should total $6.8 billion in 2015 and $12.5 billion by 2020, registering a compound annual growth rate (CAGR) of 13.0%.
Report Includes
- An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
- Analyses of global market trends, with data from 2014, estimates for 2015 and projections of compound annual growth rates (CAGRs) through 2020
- Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
- Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
- Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
- Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
- Patent analysis
- Company profiles of major players in the field
Report Highlights
The global market for metabolomics was valued at $712 million in 2012 and is expect to reach nearly $1.4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 14.2%.
Report Includes
- An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
- Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
- Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
- Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
- Patent analysis
- Comprehensive company profiles of major players
Related Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Antibody-Drug Conjugates: Technologies and Global Markets
The global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More